Lipinski's rule of five is a set of rules that determines the oral bioavailability of drug molecules. A drug-like molecule usually refers to a compound that is pharmacologically active and has the potential to be developed into a drug. When a compound is said to not violate any rule of Lipinski's rule of five, it means that the compound has passed the test for the following parameters: molecular weight, lipophilicity, hydrogen bond donors, and hydrogen bond acceptors. These properties are essential for a compound to be absorbed by the gastrointestinal tract and reach systemic circulation, eventually reaching the target site of action to produce the desired therapeutic effect.What is the count of Lipinski's rule of five that this molecule does not comply with?